|
1
|
Perez-Sayans M, Somoza-Martin JM,
Barros-Angueira F, Reboiras-Lopez MD, Gandara Rey JM and
Garcia-Garcia A: Genetic and molecular alterations associated with
oral squamous cell cancer (Review). Oncol Rep. 22:1277–1282. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi S and Myers JN: Molecular
pathogenesis of oral squamous cell carcinoma: implications for
therapy. J Dent Res. 87:14–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vairaktaris E, Spyridonidou S, Papakosta
V, et al: The hamster model of sequential oral oncogenesis. Oral
Oncol. 44:315–324. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ginos MA, Page GP, Michalowicz BS, et al:
Identification of a gene expression signature associated with
recurrent disease in squamous cell carcinoma of the head and neck.
Cancer Res. 64:55–63. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perez-Sayans M, Pilar GD, Barros-Angueira
F, Suarez-Penaranda JM, et al: Current trends in miRNAs and their
relationship with oral squamous cell carcinoma. J Oral Pathol Med.
41:433–443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shah NG, Trivedi TI, Tankshali RA, et al:
Prognostic significance of molecular markers in oral squamous cell
carcinoma: a multivariate analysis. Head Neck. 31:1544–1556. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gallant P and Steiger D: Myc’s secret life
without Max. Cell Cycle. 8:3848–3853. 2009.
|
|
8
|
Pelengaris S, Khan M and Evan G: c-MYC:
more than just a matter of life and death. Nat Rev Cancer.
2:764–776. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Whyte DA, Broton CE and Shillitoe EJ: The
unexplained survival of cells in oral cancer: what is the role of
p53? J Oral Pathol Med. 31:125–133. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lebofsky R and Walter JC: New
Myc-anisms for DNA replication and tumorigenesis? Cancer
Cell. 12:102–103. 2007.
|
|
11
|
Spandidos DA, Yiagnisis M, Papadimitriou K
and Field JK: ras, c-myc and c-erbB-2 oncoproteins in human breast
cancer. Anticancer Res. 9:1385–1393. 1989.PubMed/NCBI
|
|
12
|
Varley JM, Swallow JE, Brammar WJ,
Whittaker JL and Walker RA: Alterations to either c-erbB-2(neu) or
c-myc proto-oncogenes in breast carcinomas correlate with poor
short-term prognosis. Oncogene. 1:423–430. 1987.PubMed/NCBI
|
|
13
|
Riou GF: Proto-oncogenes and prognosis in
early carcinoma of the uterine cervix. Cancer Surv. 7:441–456.
1988.PubMed/NCBI
|
|
14
|
Field JK, Spandidos DA, Stell PM, Vaughan
ED, Evan GI and Moore JP: Elevated expression of the c-myc
oncoprotein correlates with poor prognosis in head and neck
squamous cell carcinoma. Oncogene. 4:1463–1468. 1989.PubMed/NCBI
|
|
15
|
Nakagawa M, Takizawa N, Narita M, Ichisaka
T and Yamanaka S: Promotion of direct reprogramming by
transformation-deficient Myc. Proc Natl Acad Sci USA.
107:14152–14157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Adams JM, Kelly PN, Dakic A, Carotta S,
Nutt SL and Strasser A: Role of ‘cancer stem cells’ and cell
survival in tumor development and maintenance. Cold Spring Harb
Symp Quant Biol. 73:451–459. 2008.
|
|
17
|
Eilers M and Eisenman RN: Myc’s broad
reach. Genes Dev. 22:2755–2766. 2008.
|
|
18
|
Nair SK and Burley SK: Structural aspects
of interactions within the Myc/Max/Mad network. Curr Top Microbiol
Immunol. 302:123–143. 2006.PubMed/NCBI
|
|
19
|
American Joint Committee on Cancer. Lip
and oral cavity. Cancer Staging Manual. Edge SB, Fritz AG, Byrd DR,
Greene FL, Trotti A III and Compton CC: 7th edition. Springer; New
York: pp. 1–4. 2010
|
|
20
|
Kononen J, Bubendorf L, Kallioniemi A, et
al: Tissue microarrays for high-throughput molecular profiling of
tumor specimens. Nat Med. 4:844–847. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
World Health Organization Classification
of Tumours. Head and Neck Tumors. Pathology and Genetics. Barnes L,
Eveson JW, Reichart P and Sidransky D: 9 edition. IARC Press; Lyon:
pp. 177–180. 2005
|
|
22
|
Heagerty PJ, Lumley T and Pepe MS:
Time-dependent ROC curves for censored survival data and a
diagnostic marker. Biometrics. 56:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goessel G, Quante M, Hahn WC, et al:
Creating oral squamous cancer cells: a cellular model of
oral-esophageal carcinogenesis. Proc Natl Acad Sci USA.
102:15599–15604. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Foster KW, Ren S, Louro ID, et al:
Oncogene expression cloning by retroviral transduction of
adenovirus E1A-immortalized rat kidney RK3E cells: transformation
of a host with epithelial features by c-MYC and the zinc finger
protein GKLF. Cell Growth Differ. 10:423–434. 1999.
|
|
25
|
Perez-Sayans M, Suarez-Penaranda JM, Pilar
GD, Barros-Angueira F, Gandara-Rey JM and Garcia-Garcia A: What
real influence does the proto-oncogene c-myc have in OSCC behavior?
Oral Oncol. 47:688–692. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Freier K, Bosch FX, Flechtenmacher C, et
al: Distinct site-specific oncoprotein overexpression in head and
neck squamous cell carcinoma: a tissue microarray analysis.
Anticancer Res. 23:3971–3977. 2003.PubMed/NCBI
|
|
27
|
Baral R, Patnaik S and Das BR:
Co-overexpression of p53 and c-myc proteins linked with advanced
stages of betel- and tobacco-related oral squamous cell carcinomas
from eastern India. Eur J Oral Sci. 106:907–913. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vora HH, Shah NG, Patel DD, Trivedi TI and
Chikhlikar PR: Prognostic significance of biomarkers in squamous
cell carcinoma of the tongue: multivariate analysis. J Surg Oncol.
82:34–50. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takes RP, Baatenburg de Jong RJ, Schuuring
E, Litvinov SV, Hermans J and Van Krieken JH: Differences in
expression of oncogenes and tumor suppressor genes in different
sites of head and neck squamous cell. Anticancer Res. 18:4793–4800.
1998.PubMed/NCBI
|
|
30
|
Shah NG, Trivedi TI, Tankshali RA, et al:
Molecular alterations in oral carcinogenesis: significant risk
predictors in malignant transformation and tumor progression. Int J
Biol Markers. 22:132–143. 2007.PubMed/NCBI
|
|
31
|
Martin-Ezquerra G, Salgado R, Toll A, et
al: Multiple genetic copy number alterations in oral squamous cell
carcinoma: study of MYC, TP53, CCDN1,
EGFR and ERBB2 status in primary and metastatic
tumours. Br J Dermatol. 163:1028–1035. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fujieda S, Inuzuka M, Tanaka N, et al:
Expression of p27 is associated with Bax expression and spontaneous
apoptosis in oral and oropharyngeal carcinoma. Int J Cancer.
84:315–320. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hayry V, Makinen LK, Atula T, et al: Bmi-1
expression predicts prognosis in squamous cell carcinoma of the
tongue. Br J Cancer. 102:892–897. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takes RP, Baatenburg de Jong RJ, Wijffels
K, et al: Expression of genetic markers in lymph node metastases
compared with their primary tumours in head and neck cancer. J
Pathol. 194:298–302. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rodrigo JP, Lazo PS, Ramos S, Alvarez I
and Suarez C: MYC amplification in squamous cell carcinomas of the
head and neck. Arch Otolaryngol Head Neck Surg. 122:504–507. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Eversole LR and Sapp JP: c-myc oncoprotein
expression in oral precancerous and early cancerous lesions. Eur J
Cancer B Oral Oncol. 29B:131–135. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsuzuki H, Sunaga H, Ito T, Narita N,
Sugimoto C and Fujieda S: Reliability of platelet-derived
endothelial cell growth factor as a prognostic factor for oral and
oropharyngeal carcinomas. Arch Otolaryngol Head Neck Surg.
131:1071–1078. 2005. View Article : Google Scholar : PubMed/NCBI
|
